Biomarkers, such as C-reactive protein (CRP) and neutrophil count, are often elevated in patients with COVID-19.1 This, and experience of previous influenza pandemics, during which bacterial coinfection was common,2 has driven considerable, unnecessary antibiotic use in COVID-19 patients. This evidence concerns the gene CRP and influenza.